In contrast, epithelial cancer cells overexpress FRα on their basal surface, where it is exposed to drug-conjugated folate-targeting agents in the bloodstream, leading to a more specific destruction of cancer cells (Toffoli et al., 1998; Allard et al., 2007; Brown Jones et al., 2008). Here, FOLR1 is linked to cancer.